Atlas Trials

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Clinical trial NCT03663764 · UNKNOWN

Trial details

NCT number
NCT03663764
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Thymoma and Thymic Carcinoma
Start date
2018-08-13
Primary completion
2023-08-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.